Alphatec Stock (NASDAQ:ATEC)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$5.62

52W Range

$4.88 - $17.34

50D Avg

$5.70

200D Avg

$10.51

Market Cap

$1.10B

Avg Vol (3M)

$2.46M

Beta

1.39

Div Yield

-

ATEC Company Profile


Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier, as well as EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is headquartered in Carlsbad, California.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

839

IPO Date

Jun 12, 2006

Website

ATEC Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22Dec 21
Products And Services$482.26M$350.85M$242.26M
International Supply Agreement-$15.00K$954.00K

Fiscal year ends in Dec 23 | Currency in USD

ATEC Financial Summary


Dec 23Dec 22Dec 21
Revenue$482.26M$350.87M$243.21M
Operating Income$-133.99M$-121.10M$-108.87M
Net Income$-186.64M$-152.15M$-144.33M
EBITDA$-133.99M$-110.52M$-105.09M
Basic EPS$-1.54$-1.47$-1.50
Diluted EPS$-1.54$-1.47$-1.50

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q3 24Oct 30, 24 | 9:03 PM
Q2 24Jul 31, 24 | 8:13 PM
Q1 24May 07, 24 | 12:00 AM

Peer Comparison


TickerCompany
FNAParagon 28, Inc.
OFIXOrthofix Medical Inc.
SGHTSight Sciences, Inc.
ITGRInteger Holdings Corporation
LUNGPulmonx Corporation
LIVNLivaNova PLC
KIDSOrthoPediatrics Corp.
SIBNSI-BONE, Inc.
GMEDGlobus Medical, Inc.
AORTArtivion, Inc.
AXGNAxoGen, Inc.
ESTAEstablishment Labs Holdings Inc.
CNMDCONMED Corporation
RXSTRxSight, Inc.